InvestorsHub Logo
Followers 58
Posts 10027
Boards Moderated 1
Alias Born 09/21/2016

Re: None

Sunday, 02/03/2019 9:31:32 AM

Sunday, February 03, 2019 9:31:32 AM

Post# of 458091
sokol post: IMO: AVXL position just cannot be said any better than this.BUT...Encourage all to keep trying as Xena has skillfully shown.

We now have three clinical trials in progress, and that is where Anavex needs to spend its time and energy. I think Anavex's strategy is to proceed quietly and not make a big fuss about its CNS science and theories that fly in the face of major drug companies. It is best that it go about letting its clinical trials in Australia and Spain proceed and do the speaking instead of wearing itself down fighting against the odds in the United States drug regulatory environment that is dominated by major pharma. Like water, Anavex is seeking the path of least resistance by conducting its clinical trials elsewhere.

“Water is fluid, soft, and yielding. But water will wear away rock, which is rigid and cannot yield. As a rule, whatever is fluid, soft, and yielding will overcome whatever is rigid and hard. This is another paradox: what is soft is strong.”
? Lao Tzu

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News